Zn(II), Ni(II), Cu(II), and Fe(III) complexes of potentially bimetalating tris(pyridine- and imidazole-appended) picket-fence naphthylporphyrins with benzyl ether spacers: implications for cytochrome c oxidase active-site modeling

Atropisomerism and conformational aspects of meso-tetraarylporphyrins and related compounds

This review provides a comprehensive description of the atropisomerism of meso-di- and tetraarylporphyrins with substituents in ortho-positions of the aryl ring, as well as in corroles and in conveniently substituted phthalocyanines. Different methods of study were examined: X-ray crystallography, NMR spectroscopy (both static and dynamic aspects), classical kinetics, HPLC and theoretical calculations. Then the four atropisomers, the tautomerism of the inner protons, the 'picket fence' concept, conformationally restricted meso-tetraarylporphyrins and the influence of the metal on the conformation were discussed based on 250 references.

Rotational isomers of N-alkylpyridylporphyrins and their metal complexes. HPLC separation, (1)H NMR and X-ray structural characterization, electrochemistry, and catalysis of O(2)(.-) disproportionation

Rotational (atropo-) isomers of Mn(III) meso-tetrakis(N-alkylpyridinium-2-yl)porphyrins and corresponding metal-free porphyrin ligands (where alkyl is methyl, ethyl, n-butyl, n-hexyl) and Zn(II) meso-tetrakis(N-methyl(ethyl,n-hexyl)pyridinium-2-yl)porphyrins were separated and isolated by reverse-phase HPLC. The identity of the rotational isomers of metal-free meso-tetrakis(N-methylpyridinium-2-yl)porphyrin was established by (1)H NMR spectra and by the crystal structure of the fastest eluting fraction (R(f) = 7.7%, R(w) = 9.2%, P2(1)/c, Z = 8, a = 14.2846(15) A, b = 22.2158(24) A, c = 29.369(3) A, beta = 95.374(2) degrees ) which, in accordance with (1)H NMR interpretation, proved to be the alphabetaalphabeta isomer. This result, together with elution intensity patterns, was used to identify the fractions of other Mn(III)-porphyrins, Zn(II)-porphyrins, and corresponding metal-free ligands in the series. All of the atropoisomers were inert toward isomerization which was not observable for 30 days at room temperature and reached only 50% in 16 days at 90 degrees C in the case of the Mn(III)-ethyl analogue. However, a complete freeze-dry removal of the mobile phase from the HPLC fractions caused an almost 100% isomerization. The Mn(III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin, as a mixture of atropoisomers (AEOL-10113), has been shown to offer protection in oxidative stress injury ascribed to its high reactivity toward superoxide (k(cat) = 5.8 x 10(7) M(-1) s(-1)) as a consequence of its favorable redox potential (E(1/2) = +228 mV vs NHE). In this work, the atropoisomers were found to have similar redox potentials ranging from +240 to +220 mV, to be similarly potent catalysts of O(2)(.-) disproportionation (dismutation), with k(cat) ranging from 5.5 x 10(7) to 6.8 x 10(7) M(-1) s(-1), and not to preferentially bind to biological tissue.

Biomimetic studies of terminal oxidases: trisimidazole picket metalloporphyrins

Three biomimetic models for the binuclear Fe/Cu (heme/trisimidazole) active site of terminal oxidases, such as cytochrome c oxidase and related enzymes, have been prepared. Based upon a tetrakis(aminophenyl)porphyrin core, these models possess a single covalently linked imidazole-bearing tail on one side of the porphyrin and three imidazole "pickets" on the opposite side of the porphyrin ring. Three different imidazole picket motifs are characterized in free base, Fe, Zn, Fe/Cu, and Zn/Cu forms. A combination of NMR, EPR, and IR demonstrates that, for the N-methylimidazole systems studied, the distal Cu is bound within the trisimidazole environment in the reduced (Cu(I)) and oxidized (Cu(II)) forms. The imidazole picket substitution pattern and state of metalation have significant influence on the interaction of these compounds with CO. For imidazole picket systems containing NH groups, intramolecular H bonds compete with Cu(I) coordination of the N donors.